APA

Verhaak R. G. W., Goudswaard C. S., van Putten W., Bijl M. A., Sanders M. A., Hugens W., Uitterlinden A. G., Erpelinck C. A. J., Delwel R., Löwenberg B. & Valk P. J. M. (20060118). Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. : Blood.

Chicago

Verhaak Roel G W, Goudswaard Chantal S, van Putten Wim, Bijl Maarten A, Sanders Mathijs A, Hugens Wendy, Uitterlinden André G, Erpelinck Claudia A J, Delwel Ruud, Löwenberg Bob and Valk Peter J M. 20060118. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. : Blood.

Harvard

Verhaak R. G. W., Goudswaard C. S., van Putten W., Bijl M. A., Sanders M. A., Hugens W., Uitterlinden A. G., Erpelinck C. A. J., Delwel R., Löwenberg B. and Valk P. J. M. (20060118). Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. : Blood.

MLA

Verhaak Roel G W, Goudswaard Chantal S, van Putten Wim, Bijl Maarten A, Sanders Mathijs A, Hugens Wendy, Uitterlinden André G, Erpelinck Claudia A J, Delwel Ruud, Löwenberg Bob and Valk Peter J M. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. : Blood. 20060118.